H
HTBT
Provincial-level demonstration base for talent introduction and introduction in anhui province
About HTBT
HTBT, based in Hefei City, Anhui Province, operates in the biopharmaceutical industry, focusing on the development and production of recombinant human insulin. The company serves healthcare providers and patients, aiming to improve diabetes management through advanced biotechnological solutions. HTBT's business model revolves around the research, development, and commercialization of biopharmaceutical products, generating revenue through the sale of its insulin products to hospitals, clinics, and pharmacies. The company is committed to social responsibility, emphasizing the creation of societal value and the advancement of healthcare. HTBT also collaborates with academic institutions, as evidenced by the establishment of the Anhui Provincial Academician Workstation, to foster innovation and scientific research in the biopharmaceutical field.
Source: Dealroom company dataAt a glance
- Founded
- 2007
- Headquarters
- Hefei, China
- Sector
- Hard Tech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- SCSinopharm Holding GuoDa Drug Store Co.
Series B and later3 investors entered at this stage
- HTHaoshi Touzi
Shanda Capital
CR Phrama Comm
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about HTBT on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See HTBT on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.